Vivos Inc. Summarizes the Health of Canine Therapy Patients Treated with IsoPet
March 04, 2019 07:00 ET
|
Vivos Inc.
Richland WA, March 04, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTCPINK: RDGL), provides a summary of the previous update on dogs that have been treated to date in the canine soft tissue sarcoma...
Vivos Inc. to Treat Advanced Canine Patient for Soft Tissue Sarcoma with IsoPet®
December 04, 2018 15:50 ET
|
Vivos Inc.
Richland, WA, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc. Successfully Administers IsoPet® to a Second Dog for Canine Sarcoma at the University of Missouri
October 26, 2018 07:00 ET
|
Vivos Inc.
Richland WA, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc reported that the second dog in a five-dog series was successfully treated yesterday with Y-90 IsoPet® at the...
Vivos Inc. Reports Strong Reception to IsoPet® At Veterinary Cancer Society Conference
October 22, 2018 07:00 ET
|
Vivos Inc.
Richland WA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to report that its attendance and presentation at the annual meeting of the Veterinary Cancer Society...
Amending and Replacing the Initial Press Release on George Sharp; Disregard the first release:
September 25, 2018 14:15 ET
|
Vivos Inc.
Richland, WA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Vivos Inc. (OTC: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc Retains Well-Known Analyst, George Sharp, as Advisor - Updated
September 25, 2018 11:12 ET
|
Vivos Inc.
Richland, WA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Vivos Inc. (OTC: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc Signs a Standstill Agreement with Debt Holders Designed to Halt the Toxic Selling and Eliminate the Secured Toxic Debt
September 24, 2018 07:00 ET
|
Vivos Inc.
Richland WA , Sept. 24, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to announce that all the debtholders of Vivos’ secured convertible debt have agreed to a ten...
Vivos Inc Sets the Stage for the Introduction of IsoPet® (RadioGel™) to the Veterinarian Community
August 02, 2018 06:00 ET
|
Vivos Inc.
Richland, WA, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) finalizes its plan to introduce IsoPet® to the veterinarian community. IsoPet® was designated as a device by the FDA and the...
Vivos Inc Obtains Trademark Protection for IsoPet®
July 30, 2018 06:00 ET
|
Vivos Inc.
Richland, WA, July 30, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) obtains IsoPet trademark protection. The U.S. Patent and Trademark Office (“USPTO”) issued the Certificate of Registration...
Vivos Inc Successfully Treats Canine Sarcoma with IsoPet™ (RadioGel™)
May 31, 2018 06:00 ET
|
Vivos Inc.
Richland, WA, May 31, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) successfully treated canine soft tissue sarcoma with its proprietary IsoPet™ (RadioGel™), a hydrogel liquid containing tiny...